KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Common Equity (2016 - 2025)

AbbVie (ABBV) has disclosed Common Equity for 14 consecutive years, with -$3.3 billion as the latest value for Q4 2025.

  • Quarterly Common Equity fell 197.21% to -$3.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.3 billion through Dec 2025, down 197.21% year-over-year, with the annual reading at -$3.3 billion for FY2025, 197.21% down from the prior year.
  • Common Equity for Q4 2025 was -$3.3 billion at AbbVie, down from -$2.6 billion in the prior quarter.
  • The five-year high for Common Equity was $17.3 billion in Q4 2022, with the low at -$3.3 billion in Q4 2025.
  • Average Common Equity over 5 years is $9.4 billion, with a median of $12.4 billion recorded in 2021.
  • The sharpest move saw Common Equity skyrocketed 285.21% in 2021, then crashed 197.21% in 2025.
  • Over 5 years, Common Equity stood at $15.4 billion in 2021, then increased by 11.99% to $17.3 billion in 2022, then plummeted by 39.86% to $10.4 billion in 2023, then tumbled by 67.64% to $3.4 billion in 2024, then plummeted by 197.21% to -$3.3 billion in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at -$3.3 billion, -$2.6 billion, and -$138.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.